BRPI0506927A - compostos orgánicos - Google Patents
compostos orgánicosInfo
- Publication number
- BRPI0506927A BRPI0506927A BRPI0506927-0A BRPI0506927A BRPI0506927A BR PI0506927 A BRPI0506927 A BR PI0506927A BR PI0506927 A BRPI0506927 A BR PI0506927A BR PI0506927 A BRPI0506927 A BR PI0506927A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- alkoxy
- hydrogen
- compounds
- haloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Abstract
COMPOSTO ORGáNICO. A presente invenção refere-se aos compostos da fórmula (1) na forma livre ou de sal, onde Ar é fenila subistituída por um ou mais substituintes selecionados de halogênio, ciano e C~ 1~-C~ 8~-haloalquila, ou naftila, R¬ 1¬ é hidrogênio, fenila opcionalmente substituída por um ou mais substituintes selecionados de halogênio, ciano, hidróxi, C~ 1~-C~ 8~-alquila, C~ 1~-C~ 8~-haloalquila, C~ 1~-C~ 8~-alcóxi, C~ 1~-C~ 8~-alcóxi-C~ 1~-C~ 8~-alquila, carbóxi, C~ 1~-C~ 8~-alcoxicarbonila e acilóxi, ou R¬ 1¬ é um grupo heterocíclico monovalente de 5 ou 6 membros, R¬ 2¬ é hidrogênio, C~ 1~-C~ 8~-alquila, acila ou -CON(R¬ 3¬)R¬ 4¬, R¬ 3¬ e R¬ 4¬ são ou independentemente hidrogênio ou C~ 1~-C~ 8~-alquila, ou junto com o átomo de nitrogênio ao qual eles estão ligados significa um grupo heterocíclico monovalente de 5 ou 6 membros, e Y é um grupo de pirimidinila ou piridazinila, opcionalmente substituído por pelo menos um grupo de C~ 1~-C~ 8~-alquila, C~ 1~-C~ 8~-alcóxi, C~ 1~-C~ 8~-alquiltio, C~ 1~-C~ 8~-alquilamino, di(C~ 1~- C~ 8~-alquil)amino ou acilamino. Os compostos são úteis como farmacêuticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0401336.3A GB0401336D0 (en) | 2004-01-21 | 2004-01-21 | Organic compounds |
PCT/EP2005/000542 WO2005070926A1 (en) | 2004-01-21 | 2005-01-20 | Thiazole derivatives as a2b antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0506927A true BRPI0506927A (pt) | 2007-06-05 |
Family
ID=31971241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0506927-0A BRPI0506927A (pt) | 2004-01-21 | 2005-01-20 | compostos orgánicos |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090233938A1 (pt) |
EP (1) | EP1709036B1 (pt) |
JP (1) | JP2007518767A (pt) |
KR (1) | KR20060129276A (pt) |
CN (1) | CN1910178B (pt) |
AT (1) | ATE388147T1 (pt) |
AU (1) | AU2005206290B2 (pt) |
BR (1) | BRPI0506927A (pt) |
CA (1) | CA2553010A1 (pt) |
DE (1) | DE602005005161T2 (pt) |
ES (1) | ES2300985T3 (pt) |
GB (1) | GB0401336D0 (pt) |
PL (1) | PL1709036T3 (pt) |
PT (1) | PT1709036E (pt) |
RU (1) | RU2374242C2 (pt) |
WO (1) | WO2005070926A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2270715B1 (es) | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
JP5341516B2 (ja) * | 2005-09-13 | 2013-11-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 2−アニリン−4−アリール置換チアゾール誘導体 |
ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
AU2007227021B2 (en) | 2006-03-17 | 2012-12-20 | Gilead Sciences, Inc. | Method of preventing and treating hepatic disease using A2B adenosine receptor antagonists |
ES2350013T3 (es) * | 2006-05-18 | 2011-01-14 | F. Hoffmann-La Roche Ag | Derivados de tiazolo-pirimidina/piridina-urea como antagonistas de receptor de adenosina a2b. |
JO2784B1 (en) | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
ES2424023T3 (es) | 2007-10-18 | 2013-09-26 | Janssen Pharmaceutica N.V. | 1,2,4-triazoles trisustituidos |
CN102066343B (zh) | 2008-03-19 | 2013-12-04 | 詹森药业有限公司 | 作为烟碱乙酰胆碱受体调节剂的三取代1,2,4-三唑类 |
WO2009135944A1 (en) | 2008-05-09 | 2009-11-12 | Janssen Pharmaceutica Nv | Trisubstituted pyrazoles as acetylcholine receptor modulators |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
ES2580702B1 (es) | 2015-02-25 | 2017-06-08 | Palobiofarma, S.L. | Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina |
CN109293652B (zh) * | 2017-07-24 | 2021-10-22 | 四川科伦博泰生物医药股份有限公司 | 一种取代的噻唑衍生物及其用途 |
WO2019072143A1 (zh) * | 2017-10-11 | 2019-04-18 | 上海迪诺医药科技有限公司 | 4-氨基吡啶衍生物、其药物组合物、制备方法及应用 |
EP3870573B1 (en) | 2018-10-24 | 2023-08-02 | LeadXpro AG | Functionalized aminotriazines |
CA3126735A1 (en) | 2019-01-11 | 2020-07-16 | Omeros Corporation | Methods and compositions for treating cancer |
WO2023139132A1 (en) * | 2022-01-19 | 2023-07-27 | Leadxpro Ag | Functionalized aminothiazoles |
GB2615307A (en) * | 2022-01-28 | 2023-08-09 | Adorx Therapeutics Ltd | Antagonist compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064418A1 (en) * | 1998-06-05 | 1999-12-16 | Novartis Ag | Aryl pyridinyl thiazoles |
JP2000281685A (ja) * | 1999-01-28 | 2000-10-10 | Takeda Chem Ind Ltd | チアゾロピリミジン化合物、その製造法および用途 |
WO2001030778A1 (en) * | 1999-10-27 | 2001-05-03 | Novartis Ag | Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use |
GB0028383D0 (en) * | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
JP2002302445A (ja) * | 2001-02-02 | 2002-10-18 | Takeda Chem Ind Ltd | Jnk阻害剤 |
GB0123589D0 (en) * | 2001-10-01 | 2001-11-21 | Syngenta Participations Ag | Organic compounds |
US20050004134A1 (en) * | 2001-11-08 | 2005-01-06 | Hideo Tsutsumi | Thiazole derivative and pharmaceutical use thereof |
-
2004
- 2004-01-21 GB GBGB0401336.3A patent/GB0401336D0/en not_active Ceased
-
2005
- 2005-01-20 BR BRPI0506927-0A patent/BRPI0506927A/pt not_active IP Right Cessation
- 2005-01-20 AU AU2005206290A patent/AU2005206290B2/en not_active Ceased
- 2005-01-20 JP JP2006550041A patent/JP2007518767A/ja active Pending
- 2005-01-20 CA CA002553010A patent/CA2553010A1/en not_active Abandoned
- 2005-01-20 PT PT05706936T patent/PT1709036E/pt unknown
- 2005-01-20 KR KR1020067014629A patent/KR20060129276A/ko not_active Application Discontinuation
- 2005-01-20 WO PCT/EP2005/000542 patent/WO2005070926A1/en active Application Filing
- 2005-01-20 ES ES05706936T patent/ES2300985T3/es active Active
- 2005-01-20 EP EP05706936A patent/EP1709036B1/en not_active Not-in-force
- 2005-01-20 AT AT05706936T patent/ATE388147T1/de not_active IP Right Cessation
- 2005-01-20 US US10/585,614 patent/US20090233938A1/en not_active Abandoned
- 2005-01-20 CN CN2005800026886A patent/CN1910178B/zh not_active Expired - Fee Related
- 2005-01-20 PL PL05706936T patent/PL1709036T3/pl unknown
- 2005-01-20 DE DE602005005161T patent/DE602005005161T2/de active Active
- 2005-01-20 RU RU2006130002/04A patent/RU2374242C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20090233938A1 (en) | 2009-09-17 |
GB0401336D0 (en) | 2004-02-25 |
ES2300985T3 (es) | 2008-06-16 |
JP2007518767A (ja) | 2007-07-12 |
DE602005005161T2 (de) | 2009-03-19 |
WO2005070926A1 (en) | 2005-08-04 |
AU2005206290B2 (en) | 2008-12-04 |
PT1709036E (pt) | 2008-05-28 |
CN1910178A (zh) | 2007-02-07 |
KR20060129276A (ko) | 2006-12-15 |
CN1910178B (zh) | 2010-06-02 |
RU2374242C2 (ru) | 2009-11-27 |
ATE388147T1 (de) | 2008-03-15 |
RU2006130002A (ru) | 2008-02-27 |
EP1709036B1 (en) | 2008-03-05 |
DE602005005161D1 (de) | 2008-04-17 |
PL1709036T3 (pl) | 2008-08-29 |
AU2005206290A1 (en) | 2005-08-04 |
CA2553010A1 (en) | 2005-08-04 |
EP1709036A1 (en) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0506927A (pt) | compostos orgánicos | |
MY126139A (en) | Piperidine compounds for use as ccr-3 inhibitors | |
CY1124357T1 (el) | Προσδιορισμος ανισορροπιας αλληλουχιας νουκλεϊκων οξεων | |
MX2013002558A (es) | Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk). | |
RS53379B (en) | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND THE PROCEDURE FOR THEIR PREPARATION | |
MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
CY1108792T1 (el) | Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη | |
RS54047B1 (en) | PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS | |
DOP2011000061A (es) | Compuestos de pirrol | |
ECSP034611A (es) | Aminotiazoles y su uso como antagonistas del receptor de adenosina | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
DE602004022404D1 (de) | 4-anilino-chinazolin-derivate als proliferationshemmende mittel | |
EA201170096A1 (ru) | Замещенные производные пиримидона | |
HRP20090061T3 (en) | Purine derivatives acting as a2a receptor agonists | |
CR10034A (es) | Derivados de oxadiazol | |
EA201170098A1 (ru) | Замещенные производные алкилпиримидин-4-она | |
TW200726750A (en) | Stilbene derivatives, light-emitting element and light-emitting device | |
WO2009095792A3 (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
EA200700758A1 (ru) | Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ | |
TW200602456A (en) | Anthracene compound and organic electroluminescent device including the anthracene compound | |
NO20073787L (no) | Nye pyrimidin-nukleosidforbindelser eller dets salt | |
DK1706414T3 (da) | Fremgangsmåde til fluorcytidinderivater | |
CY1107101T1 (el) | Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ | |
CY1112279T1 (el) | Εποξειδικη ενωση και μεθοδος για την παρασκευη της | |
EP2612848A4 (en) | CYCLIC AMIDE DERIVATIVE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |